| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Novavax Inc (NVAX) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 107 sells. NVAX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 264.1K | $2.38M | - | |
| CFO | 145.1K | $1.31M | - | |
| VP | 112.7K | $1.01M | - | |
| VP | 34.9K | $313.9K | - | |
| Dir | 28.5K | $256.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23, 2021 | Young James F82 | Director | Sale+OE | 10,000 | $228.22 | $2,282,230.78 | -20.8% | -17.7% | -63.5% | |
| Mar 19, 2021 | McManus Michael A Jr81 | Director | Sell | 4,000 | $220.78 | $883,110.00 | -21.2% | -21.2% | -63.9% | |
| Mar 17, 2021 | Glenn Gregory M88 | President, R&D | Sale+OE | 8,135 | $204.63 | $1,664,704.33 | -10.2% | -17.0% | -64.9% | |
| Mar 15, 2021 | Evans Gary C | Director | Sale+OE | 24,500 | $211.21 | $5,174,536.00 | -34.3% | -4.5% | -66.1% | |
| Mar 9, 2021 | Trizzino John86 | EVP, Chief Commercial Officer | Sale+OE | 3,211 | $163.74 | $525,761.12 | -9.7% | - | - | |
| Feb 26, 2021 | Herrmann John A III91 | EVP, Chief Legal Officer | Sale+OE | 2,895 | $225.48 | $652,759.28 | -12.3% | - | - | |
| Feb 18, 2021 | Glenn Gregory M88 | President, R&D | Sell | 2,434 | $269.57 | $656,134.14 | -4.9% | - | - | |
| Feb 16, 2021 | Glenn Gregory M88 | President, R&D | Sale+OE | 5,712 | $282.71 | $1,614,811.95 | -5.3% | - | - | |
| Feb 9, 2021 | Trizzino John86 | EVP, Chief Commercial Officer | Sale+OE | 3,216 | $292.51 | $940,719.27 | -12.9% | - | - | |
| Feb 1, 2021 | Herrmann John A III91 | EVP, Chief Legal Officer | Sale+OE | 15,022 | $241.50 | $3,627,788.72 | -30.7% | - | - |